Y-90 Radioembolization for Liver Tumours in Germany

Hearing that your liver tumour can’t be removed with surgery is hard news. The next question is usually, “Is there anything else that can reach the tumour without harming the rest of my liver?”

Y-90 radioembolization is one answer. It places tiny radioactive beads inside the blood vessels that feed a liver tumour, so the radiation works from the inside. Doctors in Germany use it for primary liver cancer and for cancers that have spread to the liver. You can read our wider guide to liver cancer treatment in Germany for the full range of options.

At Cancer Rounds, we hear from patients abroad who want a clear picture before they travel. This guide explains how the treatment works, who it suits, what the evidence says and what recovery looks like. It also covers the practical side of having it in Germany as an international patient.

We’ll be honest about what Y-90 can and can’t do. The right choice depends on your tumour and on how well your liver is working.

What Is Y-90 Radioembolization and How Does It Work?

Y-90 radioembolization injects tiny beads filled with radioactive yttrium-90 into the artery that feeds a liver tumour. The beads deliver a high dose of radiation to the cancer cells. Most of the healthy liver relies on a different blood supply, so it takes less of the hit.

Your liver has two blood supplies: the hepatic artery and the portal vein. Liver tumours tend to depend on the hepatic artery. That’s why an interventional radiologist places the beads in the vessels feeding the tumour, which is what makes the treatment “selective”.

Two types of beads are in use, made of glass or resin. Outcomes with the two are comparable, so the choice usually comes down to your tumour, your liver and the dose your team plans.

Y-90 isn’t chemotherapy, and it isn’t external radiotherapy. The radiation comes from inside the tumour’s own blood vessels. European interventional radiologists describe it as mainly a palliative treatment that eases symptoms rather than cures. In some patients, though, it shrinks tumours enough to allow surgery or a liver transplant.

Who Is a Good Candidate for Y-90 Radioembolization?

Y-90 radioembolization is usually offered when cancer is mostly in the liver and can’t be treated with surgery or ablation, or when drug treatment has stopped working. You also need liver function that can cope with radiation. A specialist team checks this before booking you in. European registry data describe the treatment the same way.

The treatment is used for several cancer types. A large European registry included people with hepatocellular carcinoma (HCC, the most common liver cancer), bile duct cancer inside the liver, colorectal cancer that had spread to the liver, and spread from other cancers. If you’d like a refresher, our guide to the types of liver cancer explains each one.

Doctors look at tumour size, the number of tumours and how well your liver works. This matters because results differ between groups. The largest European randomised trial, SARAH, found no overall survival benefit compared with a standard drug. A later look at one subgroup, people with a small tumour burden and good liver function, suggested more benefit, with median survival of 21.9 against 17.0 months. The authors said this needs more testing.

Some people can’t have the treatment. A planning scan measures how much of the beads would travel to the lungs. Treatment is generally avoided if that share is above 20%.

How the Treatment Works in Germany, Step by Step

Here’s what the process usually looks like at a German hospital. Timing varies by centre, so your case manager will confirm yours.

1. Team review: Liver specialists study your scans and blood tests and decide whether Y-90 suits you. You can browse liver cancer specialists in Germany before you apply.
2. Planning angiogram: A thin catheter is guided into the liver’s arteries, and dye maps which vessels feed the tumour. A nuclear scan then checks for beads reaching the lungs or other organs.
3. Test scan: A test dose of tracer particles (called MAA) is injected. It mimics the real beads and shows how much would reach the lungs. This sets the safe dose.
4. Treatment day: Planning and treatment are done as separate angiograms. On treatment day, the radioactive beads go in through the catheter.
5. Radiation-safe stay: One German university hospital says a 48-hour stay in a specially equipped ward is required. Pregnant women should keep away in the first few days.
6. Follow-up: Scans over the following weeks show how the tumour responded.

How Well Does Y-90 Work? What the Evidence Shows

Two studies give the clearest picture for HCC.

The LEGACY study followed 162 people with a single tumour up to 8 cm that couldn’t be removed. About 72% had a tumour response, and 76% of responders kept that response for at least six months. Liver function held steady in most patients. It had no comparison group, so treat the numbers as encouraging rather than final.

DOSISPHERE-01 asked whether dose planning matters. French researchers randomly assigned 60 people with large tumours to a standard dose or a personalised dose aimed at the tumour. Response was 71% with personalised dosing against 36% with the standard dose. Median survival was 22.9 against 10.8 months. It was a small phase 2 trial, but an international expert group now stresses personalised dosimetry.

Y-90 can also act as a bridge to other treatment. Ask your team whether shrinking the tumour for surgery or transplant is a realistic goal in your case. For most people with advanced disease, the aim is to control the tumour and ease symptoms rather than cure it.

What Are the Side Effects and Risks of Y-90 Radioembolization?

Most people get some tiredness, nausea, low fever or belly discomfort after Y-90 radioembolization. Doctors call this post-radioembolization syndrome, and it’s treated with supportive care. Serious problems, such as liver injury or stomach ulcers, are uncommon.

About half of patients get post-radioembolization syndrome, and a study of 112 patients put the figure at 70%. Symptoms include fatigue, belly pain, nausea, vomiting, poor appetite and fever. They typically appear within 24 to 72 hours.

Serious complications are rare. In the European CIRT registry, grade 3 or higher stomach ulcers affected 0.4% of patients, gastritis 0.3%, gallbladder inflammation 0.2% and radioembolization-induced liver disease 0.5%. In the 112-patient study, late grade 3 or 4 complications reached 8% at 12 months.

That’s why planning scans matter. They show where beads might stray, which protects your lungs, stomach and bowel. Call your care team if you notice yellowing of the skin or eyes, a high fever that won’t settle, or pain that keeps getting worse.

How Does Y-90 Compare With TACE and Other Liver Cancer Treatments?

Y-90 radioembolization often keeps tumours from growing for longer than chemoembolization (TACE), but overall survival has been similar in trials. So the choice depends on your tumour size, liver function and goals.

In the PREMIERE trial, time to progression was over 26 months with Y-90 against 6.8 months with TACE. Median survival was similar, at 18.6 against 17.7 months. It was a single-centre study of only 45 people. A pooled analysis of 10 studies and 1,557 patients agreed: similar survival and safety, with progression delayed after Y-90.

Y-90 also tends to be gentler in the short term. A Korean review found fewer post-embolization symptoms and shorter hospital stays than with TACE. If you’d like to compare, read about TACE in Germany.

Drug-based options matter too. Your team may suggest immunotherapy for advanced disease. Trials are now testing immunotherapy given after Y-90, so ask whether a combined plan could suit you.

Cost, Travel and Support for International Patients in Germany

Cost depends on your case. Our treatment cost pages are a good starting point, and for Germany we currently estimate about $15,000 to $30,000 for interventional procedures such as TACE or SIRT. Treat that as a guide. The final figure depends on the number of sessions, imaging, the hospital stay, and the dose and type of beads.

Insurance is a separate question. One German university hospital notes that statutory insurers cover SIRT only under special contracts. It asks patients without German insurance to get in touch in advance to see whether a foreign insurer might pay.

Germany isn’t new to this treatment. A German health-economics abstract estimated about 500 procedures a year, roughly a quarter of eligible HCC patients.

Cancer Rounds takes care of the practical side. You send your reports, and our medical team replies within 4 hours with a free review. You’ll get a treatment plan and quote within about two days. A dedicated case manager arranges interpreter support, visa and travel help, and a plan for sharing your results with your home doctor. We can match you with partner cancer hospitals in Germany that treat liver cancer and can confirm whether Y-90 is available for you.

Conclusion

Y-90 radioembolization gives people with inoperable liver tumours a targeted option. It works best when the tumour and your liver are well matched to the treatment. Planning and dose choice make a real difference. Side effects are common, but serious ones are uncommon.

If you’re weighing this treatment, you don’t have to work it out alone. Send us your scans and reports, and we’ll arrange a review with a specialist. Talk to a Liver Cancer Specialist or Get a Personalised Treatment Plan today. If you’re not ready yet, start a WhatsApp chat, request a callback or ask about costs. We’ll go at your pace.

Frequently Asked Questions

How long does Y-90 radioembolization take, and will I stay in hospital?

Planning and treatment are separate angiograms, so you’ll have at least two procedures. In Germany, one university hospital says a 48-hour stay in a radiation-safe ward is required. Your case manager will give you a schedule for your chosen hospital.

What are the success rates for Y-90 radioembolization?

In the LEGACY study, about 72% of people had a tumour response. In DOSISPHERE-01, personalised dosing raised response to 71% from 36%. Remember that Y-90 is generally used to ease symptoms rather than cure, so results depend on your tumour and liver.

What are the risks and complications?

Around 70% of patients in one study had post-radioembolization syndrome, which includes fatigue, nausea and fever. Serious problems are uncommon: radioembolization-induced liver disease affected 0.5% of patients in a European registry. Planning scans help lower the risk to the lungs and bowel.

How much does Y-90 radioembolization cost in Germany?

We currently estimate about $15,000 to $30,000 for interventional procedures such as TACE or SIRT in Germany. The final price depends on the number of sessions, imaging, the hospital stay and the beads used. See our cost pages or ask us for a quote based on your reports.

Can international patients have Y-90 radioembolization in Germany?

Yes. Germany performs around 500 of these procedures a year. Coverage by German insurers is usually limited to special contracts, so overseas patients should ask about costs early. Cancer Rounds handles records, visas, travel and follow-up.

Can Y-90 be repeated if the tumour comes back?

Sometimes. A small study of 21 patients found repeat treatment had an acceptable toxicity profile. Another retrospective analysis reported two deaths from liver injury after repeat whole-liver treatments. Your team will weigh your liver function carefully before suggesting it.

What tests do I need before treatment, and what is recovery like?

You’ll have blood tests, imaging, an angiogram and a nuclear scan to check for beads reaching the lungs or other organs. Afterwards, tiredness and nausea are common, and symptoms typically appear within 24 to 72 hours. Rest, fluids and the medicines your team recommends help while you recover.